CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 28 enrolled
Drug / intervention
MAXCLARITY II (2.5% BPO) Foam Cleanser +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01706263
NCT01706263Phase 4Completed
CompareCT.gov

U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne

Stiefel, a GSK Company·interventional·Posted Oct 15, 2012·Updated Jan 8, 2018

In Brief

A Phase 4 clinical trial evaluating MAXCLARITY II (2.5% BPO) Foam Cleanser, MAXCLARITY II (2.5% BPO) Foam Treatment, and 1 other intervention for Acne Vulgaris. Completed, enrolled 28 participants.

Detailed Summary

One of the main success factors in acne therapy is user compliance with treatment, product cost, availability and ease of use. Poor compliance may translate into decreased efficacy (either not improving symptoms well enough or not improving symptoms fast enough), tolerability issues or adverse effects (eg, erythema, dryness, or peeling of the skin), a lack of understanding of the instructions for use, or product cost/availability. Whatever the reason, poor compliance translates to decreased efficacy and increased frustration on the part of the user. The current study will evaluate the efficacy and tolerability of MAXCLARITY II, an over the counter, topical benzoyl peroxide (BPO) product line, in subjects with acne.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
Countries--
CollaboratorsGlaxoSmithKline

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 15, 2012
Enrollment StartAug 1, 2009
Primary CompletionNov 20, 2009
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 13.7 years ago

Interventions

MAXCLARITY II (2.5% BPO) Foam Cleanserdrug

Available over the counter.

MAXCLARITY II (2.5% BPO) Foam Treatmentdrug

Available over the counter.

MAXCLARITY II (0.5% Salicylic Acid) Toner Foamdrug

Available over the counter.